DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/a358f0d5/periodontal_diseas) has announced the addition of Global Markets Direct's new report "Periodontal Disease - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Periodontal Disease - Pipeline Review, H1 2012', provides an overview of the Periodontal Disease therapeutic pipeline. This report provides information on the therapeutic development for Periodontal Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Periodontal Disease. 'Periodontal Disease - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Key Topics Covered:
- List of Tables
- List of Figures
- Introduction
- Global Markets Direct Report Coverage
- Periodontal Disease Overview
- Therapeutics Development
- An Overview of Pipeline Products for Periodontal Disease
- Periodontal Disease Therapeutics under Development by Companies
- Periodontal Disease Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Pre-Clinical Stage Products
- Comparative Analysis
- Periodontal Disease Therapeutics - Products under Development by Companies
- Periodontal Disease Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Periodontal Disease Therapeutics Development
- Periodontal Disease - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Periodontal Disease Therapeutics - Drug Profile Updates
- Periodontal Disease Therapeutics - Dormant Products
- Periodontal Disease - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
Companies Mentioned:
- Scil Technology Gmbh
- Enzo Biochem, Inc.
- IMAGENETIX, INC
- Kaken Pharmaceutical Co.,Ltd.
- Dexcel Pharma
- Fibrocell Sciences, Inc.
- Biomedical Development Corporation.
For more information visit http://www.researchandmarkets.com/research/a358f0d5/periodontal_diseas
Source: Global Markets Direct